Catálogo de publicaciones - libros
Immune Regulation and Immunotherapy in Autoimmune Disease
Jingwu Zhang (eds.)
Resumen/Descripción – provisto por la editorial
No disponible.
Palabras clave – provistas por la editorial
Immunology; Microbiology; Infectious Diseases; Virology; Pharmacology/Toxicology
Disponibilidad
Institución detectada | Año de publicación | Navegá | Descargá | Solicitá |
---|---|---|---|---|
No detectada | 2007 | SpringerLink |
Información
Tipo de recurso:
libros
ISBN impreso
978-0-387-36002-7
ISBN electrónico
978-0-387-36003-4
Editor responsable
Springer Nature
País de edición
Reino Unido
Fecha de publicación
2007
Información sobre derechos de publicación
© Springer US 2007
Cobertura temática
Tabla de contenidos
Viral Infection and Multiple Sclerosis
Elizabeth L. Williams; Steven Jacobson
Palabras clave: Multiple Sclerosis; Experimental Autoimmune Encephalomyelitis; Progressive Multifocal Leukoencephalopathy; Human Herpesvirus; Immediate Early.
Part I - Immune Regulation and Autoimmune Disease | Pp. 188-213
Multiple Sclerosis Pathology During Early and Late Disease Phases: Pathogenic and Clinical Relevance
Claudia F. Lucchinetti
Palabras clave: Multiple Sclerosis; Multiple Sclerosis Lesion; Myelin Oligodendrocyte Glycoprotein; Normal Appear White Matter; Late Disease.
Part I - Immune Regulation and Autoimmune Disease | Pp. 214-264
CD8+ T Cells in Multiple Sclerosis
Manuel A. Friese; Lars Fugger
Palabras clave: Multiple Sclerosis; Major Histocompatibility Complex; Celiac Disease; Experimental Autoimmune Encephalomyelitis; Major Histocompatibility Complex Class.
Part I - Immune Regulation and Autoimmune Disease | Pp. 265-285
Review of Novel Immunotherapeutic Strategies for MS
Heinz Wiendl; Reinhard Hohlfeld
Palabras clave: Multiple Sclerosis; Experimental Autoimmune Encephalomyelitis; Multiple Sclerosis Patient; Major Histocompatibility Complex Class; Glatiramer Acetate.
Part II - Novel Immunotherapeutic Strategies and Emerging Treatments | Pp. 289-338
T Cell Vaccination in Autoimmune Disease
Sheri M. Skinner; Ying C. Q. Zang; Jian Hong; Jingwu Z. Zhang
Palabras clave: Multiple Sclerosis; Experimental Autoimmune Encephalomyelitis; Multiple Sclerosis Patient; Cell Clone; Myelin Basic Protein.
Part II - Novel Immunotherapeutic Strategies and Emerging Treatments | Pp. 339-368
Trivalent T Cell Receptor Peptide Vaccine for Treatment of Multiple Sclerosis Targets Predominant V Genes Widely Implicated in Autoimmune Diseases and Allergy
Arthur A. Vandenbark; Nicole E. Culbertson
Palabras clave: Treg Cell; Versus Gene; Recombination Signal Sequence; Multiple Sclerosis Treatment; Cell Receptor Versus.
Part II - Novel Immunotherapeutic Strategies and Emerging Treatments | Pp. 369-408
Nonmyeloablative Stem Cell Transplantation for Multiple Sclerosis
Richard K. Burt; Yvonne Loh; Larissa Verda
Palabras clave: Multiple Sclerosis; Hematopoietic Stem Cell Transplantation; Experimental Autoimmune Encephalomyelitis; Expand Disability Status Scale; Graft Versus Host Disease.
Part II - Novel Immunotherapeutic Strategies and Emerging Treatments | Pp. 409-424
T Cell-Targeted Therapy for Rheumatoid Arthritis
Hendrik Schulze-Koops; Peter E. Lipsky
Palabras clave: Rheumatoid Arthritis; Rheumatic Disease; Psoriatic Arthritis; Autoimmune Inflammation; Tumor Necrosis Factor Alpha Inhibition.
Part II - Novel Immunotherapeutic Strategies and Emerging Treatments | Pp. 425-437
Estrogens in the Treatment of Multiple Sclerosis
Rhonda R. Voskuhl
Palabras clave: Multiple Sclerosis; Experimental Autoimmune Encephalomyelitis; Estrogen Treatment; Estrogen Receptor Alpha; Experimental Autoimmune Encephalomyelitis Model.
Part II - Novel Immunotherapeutic Strategies and Emerging Treatments | Pp. 438-460
Immune Regeneration Through Hematopoietic Stem Cell Transplantation to Restore Tolerance in Autoimmune Disease
Paolo A. Muraro
Palabras clave: Multiple Sclerosis; Systemic Lupus Erythematosus; Hematopoietic Stem Cell Transplantation; Experimental Autoimmune Encephalomyelitis; Myelin Basic Protein.
Part II - Novel Immunotherapeutic Strategies and Emerging Treatments | Pp. 461-479